Development and validation of the Nancy histological index for UC A Marchal-Bressenot, J Salleron, C Boulagnon-Rombi, C Bastien, V Cahn, ... Gut 66 (1), 43-49, 2017 | 378 | 2017 |
Viral causes of human myocarditis L Andréoletti, N Lévêque, C Boulagnon, C Brasselet, P Fornes Archives of cardiovascular diseases 102 (6-7), 559-568, 2009 | 266 | 2009 |
Comparing histological activity indexes in UC A Bressenot, J Salleron, C Bastien, S Danese, C Boulagnon-Rombi, ... Gut 64 (9), 1412-1418, 2015 | 146 | 2015 |
Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics C Boulagnon-Rombi, C Fleury, C Fichel, S Lefour, A Marchal Bressenot, ... Journal of Neuropatholgy & Experimental Neurology 76 (4), 289-298, 2017 | 105 | 2017 |
the histological assessment of disease activity in ulcerative colitis A Marchal Bressenot, RH Riddell, C Boulagnon‐Rombi, W Reinisch, ... Alimentary pharmacology & therapeutics 42 (8), 957-967, 2015 | 88 | 2015 |
Post-mortem biochemistry of vitreous humor and glucose metabolism: an update C Boulagnon, R Garnotel, P Fornes, P Gillery Clinical Chemistry and Laboratory Medicine (CCLM) 49 (8), 1265-1270, 2011 | 76 | 2011 |
A fatal case of Human Herpesvirus 6 chronic myocarditis in an immunocompetent adult N Leveque, C Boulagnon, C Brasselet, F Lesaffre, D Boutolleau, D Metz, ... Journal of Clinical Virology 52 (2), 142-145, 2011 | 57 | 2011 |
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX JF Emile, C Julié, K Le Malicot, C Lepage, J Tabernero, E Mini, ... European journal of cancer 82, 16-24, 2017 | 44 | 2017 |
Functional interplay between collagen network and cell behavior within tumor microenvironment in colorectal cancer CC Le, A Bennasroune, B Langlois, S Salesse, C Boulagnon-Rombi, ... Frontiers in oncology 10, 527, 2020 | 42 | 2020 |
COVID-19 epidemic: proposed alternatives in the management of digestive cancers: a French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) F Di Fiore, O Bouché, C Lepage, D Sefrioui, A Gangloff, L Schwarz, ... Digestive and Liver Disease 52 (6), 597-603, 2020 | 39 | 2020 |
Signaling of serum amyloid A through receptor for advanced glycation end products as a possible mechanism for uremia-related atherosclerosis K Belmokhtar, T Robert, J Ortillon, A Braconnier, V Vuiblet, ... Arteriosclerosis, Thrombosis, and Vascular Biology 36 (5), 800-809, 2016 | 37 | 2016 |
Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co … K Belmokhtar, J Ortillon, S Jaisson, ZA Massy, C Boulagnon Rombi, ... Nephrology Dialysis Transplantation 34 (12), 2018-2030, 2019 | 34 | 2019 |
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide A Jeanne, V Untereiner, C Perreau, I Proult, C Gobinet, ... Scientific reports 7 (1), 7700, 2017 | 34 | 2017 |
Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy N Lévêque, F Renois, D Talmud, Y Nguyen, F Lesaffre, C Boulagnon, ... Journal of clinical microbiology 50 (10), 3378-3380, 2012 | 33 | 2012 |
LRP1 expression in colon cancer predicts clinical outcome C Boulagnon-Rombi, C Schneider, C Leandri, A Jeanne, V Grybek, ... Oncotarget 9 (10), 8849, 2018 | 28 | 2018 |
Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy CT Nguyen, S Caruso, P Maille, A Beaufrère, J Augustin, L Favre, ... Clinical Cancer Research 28 (3), 540-551, 2022 | 27 | 2022 |
Collagen-based medical device as a stem cell carrier for regenerative medicine L Aubert, M Dubus, H Rammal, C Bour, C Mongaret, C Boulagnon-Rombi, ... International Journal of Molecular Sciences 18 (10), 2210, 2017 | 26 | 2017 |
Identification of TAX2 peptide as a new unpredicted anti-cancer agent A Jeanne, E Sick, J Devy, N Floquet, N Belloy, L Theret, ... Oncotarget 6 (20), 17981, 2015 | 23 | 2015 |
Filiform polyposis: a benign entity? Case report and literature review C Boulagnon, JF Jazeron, A Diaz-Cives, F Ehrhard, O Bouché, ... Pathology-Research and Practice 210 (3), 189-193, 2014 | 22 | 2014 |
Harnessing Wharton’s jelly stem cell differentiation into bone-like nodule on calcium phosphate substrate without osteoinductive factors SM Alami, H Rammal, C Boulagnon-Rombi, F Velard, F Lazar, R Drevet, ... Acta Biomaterialia 49, 575-589, 2017 | 21 | 2017 |